FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth dru - 1br

1BN-General 2022-10-20

Views 3

The FDA advisory panel, made up of gynecologists, obstetricians and other fetal medicine experts, voted 14-1 to withdraw Makena from the market.

VIEW MORE : https://bit.ly/1breakingnews

Share This Video


Download

  
Report form